Key Events This Week
27 Jul: New 52-week high at Rs.1,893.65 and record quarterly results announced
27 Jul: Intraday high surge of 7.47% with strong institutional buying
30 Jul: New 52-week high at Rs.1,910 amid positive sector momentum
31 Jul: Week closes at Rs.1,907.50, up 1.55% on the day

Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1910
2026-07-30 09:48:11With every major technical indicator aligned to the upside, Dr Lal Pathlabs Ltd surged to a fresh 52-week high of Rs 1910 on 30 Jul 2026, marking a significant milestone in its price momentum journey.
Read full news article
Dr Lal Pathlabs Ltd Surges on High-Value Trading and Institutional Interest
2026-07-27 10:00:17Dr Lal Pathlabs Ltd (LALPATHLAB) emerged as one of the most actively traded stocks by value on 27 Jul 2026, registering a robust 6.41% gain and hitting a new 52-week high of Rs 1894.9. The healthcare services company’s strong performance was underpinned by significant institutional participation, elevated delivery volumes, and a sustained upward price momentum that outpaced both its sector and the broader market indices.
Read full news article
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1893.65
2026-07-27 09:55:56Surging to an intraday peak of Rs 1893.65 on 27 Jul 2026, Dr Lal Pathlabs Ltd has marked a fresh 52-week high, extending its upward momentum amid a backdrop of robust technical signals and steady market conditions.
Read full news article
Dr Lal Pathlabs Ltd Surges 7.47% to Day's High of Rs 1893.65 — Outperforms Sector by 7.05 Percentage Points
2026-07-27 09:32:31The Sensex advanced 0.81% on 27 Jul 2026, yet Dr Lal Pathlabs Ltd outpaced the broader market with a 7.47% gain, reaching a fresh 52-week high of Rs 1893.65. This 7.05 percentage-point outperformance over its Healthcare Services sector peers highlights a distinctly stock-specific rally rather than a mere market tailwind.
Read full news article
Dr Lal Pathlabs Ltd Reports Strongest Quarterly Performance, Upgrades Financial Trend
2026-07-27 08:00:23Dr Lal Pathlabs Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, prompting MarketsMOJO to upgrade its rating from Hold to Buy. The healthcare services company posted record quarterly figures across key metrics, signalling a positive shift in its growth trajectory and operational efficiency.
Read full news article
Dr Lal Pathlabs Ltd is Rated Buy
2026-07-26 10:10:29Dr Lal Pathlabs Ltd is rated Buy by MarketsMOJO, with this rating last updated on 24 July 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 26 July 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.
Read full news article







